Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
08/2012
08/22/2012CN101485751B Cotinus coggygria compound preparation and use
08/22/2012CN101480405B Oryzanol composition and preparation method thereof
08/22/2012CN101327286B Pain-relieving anti-inflammation medicament and preparation method thereof and use
08/22/2012CN101282988B EGLN2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart diseases
08/22/2012CN101268054B Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, pharmaceutical compositions and therapeutic use
08/21/2012US8247448 Butenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and use for the treatment of dyslipidaemia, atherosclerosis and diabetes
08/21/2012CA2497351C Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same
08/21/2012CA2483848C Antibody against human insulin-like growth factor
08/21/2012CA2472920C Methods of reducing angiogenesis
08/21/2012CA2469076C Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses
08/21/2012CA2408032C Preparation for the prevention and/or treatment of vascular disorders
08/21/2012CA2371723C Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
08/21/2012CA2288143C Activated protein c formulations
08/16/2012WO2012109570A1 Viral vectors with modified transduction profiles and methods of making and using the same
08/16/2012WO2012109406A1 Methods for treating pulmonary hypertension
08/16/2012WO2012109297A2 Atrial appendage occlusion and arrhythmia treatment
08/16/2012WO2012109065A2 Treatment and prevention of cardiovascular disease and thrombosis
08/16/2012WO2012108650A2 Uses of a monoclonal antibody to proteinase-3 as a therapeutic agent or as a diagnostic agent for a stroke
08/16/2012WO2012108478A1 Monocyclic compound
08/16/2012WO2012108379A1 Therapeutic agent for diastolic congestive heart failure
08/16/2012WO2012079721A8 Terpenoid spiro ketal compounds with lxr agonists activity, their use and formulations with them
08/16/2012WO2012078746A9 Compositions and methods for mobilizing stem cells
08/16/2012WO2012075081A3 High-strength testosterone undecanoate compositions
08/16/2012WO2012074676A3 Glp-1 agonists, dpp-4 inhibitors, compositions, and uses related thereto
08/16/2012WO2012047966A4 Compositions and methods for treating ocular edema, neovascularization and related diseases
08/16/2012WO2011105099A8 Compound containing a novel 4-alkoxypyrimidine formation and medicine containing same
08/16/2012WO2008144483A3 Agents for treating disorders involving modulation of ryanodine receptors
08/16/2012US20120209050 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
08/16/2012US20120209012 Compounds, compositions and methods
08/16/2012US20120208993 Synthetic heparin trisaccharides
08/16/2012US20120208889 Class- and isoform-specific hdac inhibitors and uses thereof
08/16/2012US20120208875 Method for inhibiting blood vessel stenosis
08/16/2012US20120208854 Therapeutic combination
08/16/2012US20120208852 Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
08/16/2012US20120208843 Method of Using GPR35 to Identify Metabolic-Stabilizing Compounds
08/16/2012US20120208840 Condensed Ring Pyridine Compounds As Subtype-Selective Modulators Of Sphingosine-1-Phosphate-2 (S1P2) Receptors
08/16/2012US20120208838 Diuretics
08/16/2012US20120208830 Anhydrous Crystalline Forms of N-[1-(2-ethoxyethyl)-5-(N-ethyl-N-methylamino)-7-(4-methylpyridin-2-yl-amino)-1H-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide
08/16/2012US20120208818 Compounds useful as antagonists of ccr2
08/16/2012US20120208817 Novel Dihydropyrimidin-2(1H)-one Compounds as S-Nitrosoglutathione Reductase Inhibitors
08/16/2012US20120208816 Organic compounds
08/16/2012US20120208812 DISUBSTITUTED OCTAHYDROPYRROLO[3,4-c]PYRROLES AS OREXIN RECEPTOR MODULATORS
08/16/2012US20120208808 Pyrazolopyrimidine derivatives
08/16/2012US20120208805 Triazolium salts as par1 inhibitors, production thereof, and use as medicaments
08/16/2012US20120208804 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
08/16/2012US20120208793 Thieno- and furo-pyrimidine modulators of the histamine h4 receptor
08/16/2012US20120208790 Ion channel modulators and methods of use
08/16/2012US20120208786 Bisphosphonate compositions and methods for treating heart failure
08/16/2012US20120208777 Diosmetin compounds, a process for their preparation and pharmaceutical compositions containing them
08/16/2012US20120208774 Method for inhibiting "melanoma inhibitory activity" mia
08/16/2012US20120208762 Methods of Diagnosing Diastolic Dysfunction
08/16/2012US20120208757 Use of hyaluronan for promoting angiogenesis
08/16/2012US20120208751 Methods for Regulating Neurotransmitter Systems by Inducing Counteradaptations
08/16/2012US20120208748 Peptide compositions and methods for treating patients
08/16/2012US20120208747 Novel peptide for augmenting and expression of bdnf and pharmaceutical composition for prevention and treatment of neurodegenerative diseases including alzheimer's disease or parkinson's disease, comprising the same
08/16/2012US20120207825 Pharmaceutical compositions for reducing alcohol-induced dose dumping
08/16/2012US20120207822 Compositions and methods for treatment of cardiovascular disease
08/16/2012US20120207800 Compositions
08/16/2012US20120207756 Modified Antibody Compositions, Methods of Making and Using Thereof
08/16/2012US20120207749 Dosing regimen
08/16/2012US20120207743 Inhibiting Aberrant Blood Vessel Formation Using Retargeted Endopeptidases
08/16/2012US20120207734 Methods of Inhibiting Aberrant Blood Vessel Formation Using Opioid Retargeted Endpeptidases
08/16/2012US20120207729 Substituted benzoazole pde4 inhibitors for treating pulmonary and cardiovascular disorders
08/16/2012US20120207725 Mesenchymal stem cell incorporating a nucleotide sequence coding tgfb, and uses thereof
08/16/2012US20120207722 Use Of Adipose Tissue Cells For Initiating The Formation Of A Functional Vascular Network
08/16/2012US20120207716 Cardiac Muscle Regeneration Using Mesenchymal Stem Cells
08/16/2012US20120207715 Methods and systems for storing and prolonging viability of matrix dependent cells
08/16/2012US20120207714 Compositions comprising vascular and myocyte progenitor cells and methods of their use
08/16/2012US20120207713 Probiotic bifidobacterium strains
08/16/2012US20120207704 Inhibiting Aberrant Blood Vessel Formation Using Growth Factor Retargeted Endopeptidases
08/16/2012US20120207681 Chemical compositions to detect and treat amyloid in a patients brain and retina
08/16/2012US20120207680 Methods of Identifying Candidate Compounds of the Human G Protein-Coupled Receptor, GPR50, as Modulators of Body Mass or Adiposity
08/16/2012DE102011011402A1 Preparing a composition, useful to prepare functional food, comprises mixing milled tartary buckwheat with a protein solution, leaving the mixture for a specified range of seconds and cooling the mixture at specified range of temperature
08/16/2012CA2827154A1 Methods for treating pulmonary hypertension
08/16/2012CA2827056A1 Microporous zirconium silicate for the treatment of hyperkalemia
08/16/2012CA2826972A1 Treatment and prevention of cardiovascular disease and thrombosis
08/16/2012CA2826663A1 Therapeutic agent for diastolic congestive heart failure
08/16/2012CA2826273A1 Viral vectors with modified transduction profiles and methods of making and using the same
08/15/2012EP2487178A1 Pyrazolothiazole compound
08/15/2012EP2487177A1 Pyrazoloxazole compound
08/15/2012EP2487174A2 Tricyclic and tetracyclic systems with activity on the central-nervous and vascular systems
08/15/2012EP2486042A1 Bicyclic heterocycles and their use as ccr2 receptor antagonists
08/15/2012EP2486010A2 Novel estrogen receptor ligands
08/15/2012EP2486009A1 2h-pyrrol-5-amine derivatives as alpha adrenergic receptor modulators
08/15/2012EP2485768A1 Methods and compositions related to clot-binding lipid compounds
08/15/2012EP2485743A1 Lactobacillus plantarum strains as hypocholesterolemic agents.
08/15/2012EP2485718A1 Use of a compound based on eremophilanolides
08/15/2012EP2485596A1 Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
08/15/2012EP2271643B1 Oxadiazoles as s1p1 receptor agonists
08/15/2012EP2257546B1 Functionally selective alpha2c adrenoreceptor agonists
08/15/2012EP2238143B1 Nitric oxide donor compounds
08/15/2012EP2190837B1 4-pyrimidinesulfamide derivative
08/15/2012EP2146988B1 New 4,8-diphenyl-polyazanaphthalene derivatives
08/15/2012EP2142185B1 Droxidopa and pharmaceutical composition thereof for the treatment of neurally mediated hypotension
08/15/2012EP2139488B1 Use of riboflavin in the treatment of hypertension
08/15/2012EP2102185B1 Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
08/15/2012EP1894567B1 Concomitant pharmaceutical agents and use thereof
08/15/2012EP1642899B1 2,4-bis(trifluoroethoxy)pyridine compound and medicine containing the same
08/15/2012EP1461347B8 2-o-(beta-d-glucopyranosyl)ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it
08/15/2012EP1438295B1 Azole derivatives and pharmaceutical compositions containing them
1 ... 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 ... 1595